116
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Two new anti-inflammatory trachylobane diterpenoids from Euphorbia atoto

, , , , , & show all
Pages 313-319 | Received 08 Mar 2023, Accepted 08 Jun 2023, Published online: 21 Jun 2023
 

Abstract

Two new rare trachylobane euphoratones A-B (1-2), together with five known diterpenoids (compounds 3-7), were isolated from the aerial parts of Euphorbia atoto. Their structures were unambiguously elucidated through HRESIMS, 1D and 2D NMR spectral analysis. Compounds 1, 3, 4 and 7 showed weak anti-inflammatory activities (IC50 77.49 ± 6.34, 41.61 ± 14.49, 16.00 ± 1.71 and 33.41 ± 4.52 μM, respectively), compared to the positive control quercetin (IC50 15.23 ± 0.65 μM).

Acknowledgements

The authors are grateful to the members of the analytical group of Institute of Tropical Bioscience and Biotechnology, Chinese Academy of Tropical Agricultural Sciences for the spectral measurements. The authors thank Dr. Y.L. Huang (Dept. of Translational Medicine; Jiangsu Hengrui Medicine Shanghai, China) for proofreading this manuscript.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

This work was financially supported by Financial Fund of the Ministry of Agriculture and Rural Affairs, China [NFZX2021] and the China Agriculture Research System [CARS-21].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.